TCG Crossover Management (TCGX)
Palo Alto, USA · Growth → Series C+
Their stated focus (public profile)
TCG Crossover (TCGX) is a science-driven investment firm focused on innovative biotech companies developing transformative medicines. They invest in visionary entrepreneurs leveraging recent scientific breakthroughs and support both private and public companies at any stage of their lifecycle. They operate closed-end funds allowing patient, long-term capital commitment and maintain a global network of scientific advisors including Nobel Prize and Lasker Award recipients.
Stages: Growth → Series C+
Sectors: Life sciences, Healthtech
Website: tcgcrossover.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.